Global Next-Generation Biologics Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 19-Jan-2023
No. of pages: 123

The report focuses on the Next-Generation Biologics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Next-Generation Biologics market.

Major Players in the Next-Generation Biologics market are:

Eli Lilly

Roche

Novo Nordisk

Allergan

Biogen Idec

Kyowa Hakko Kirin

Molecular Partners

Pfizer

Sanofi

Bayer

On the basis of types, the Next-Generation Biologics market is primarily split into:

Antibodies

Regenerative medicine

Insulins

Growth hormones

Other

On the basis of applications, the market covers:

Medical

Scientific Research

Other

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Next-Generation Biologics Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Next-Generation Biologics Market Overview
1.1 Product Overview and Scope of Next-Generation Biologics Market
1.2 Next-Generation Biologics Market Segment by Type
1.2.1 Global Next-Generation Biologics Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Next-Generation Biologics Market Segment by Application
1.3.1 Next-Generation Biologics Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Next-Generation Biologics Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Next-Generation Biologics (2017-2029)
1.5.1 Global Next-Generation Biologics Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Next-Generation Biologics Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Next-Generation Biologics Industry
1.7 Impact of Carbon Neutrality on the Next-Generation Biologics Industry

2 Next-Generation Biologics Market Upstream and Downstream Analysis
2.1 Next-Generation Biologics Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Next-Generation Biologics Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Eli Lilly
3.1.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Next-Generation Biologics Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Roche
3.2.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Next-Generation Biologics Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Novo Nordisk
3.3.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Next-Generation Biologics Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Allergan
3.4.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Next-Generation Biologics Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Biogen Idec
3.5.1 Biogen Idec Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Next-Generation Biologics Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Kyowa Hakko Kirin
3.6.1 Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Next-Generation Biologics Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Molecular Partners
3.7.1 Molecular Partners Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Next-Generation Biologics Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Pfizer
3.8.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Next-Generation Biologics Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Sanofi
3.9.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Next-Generation Biologics Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Bayer
3.10.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Next-Generation Biologics Market Performance (2017-2022)
3.10.4 Business Overview

4 Global Next-Generation Biologics Market Landscape by Player
4.1 Global Next-Generation Biologics Sales and Share by Player (2017-2022)
4.2 Global Next-Generation Biologics Revenue and Market Share by Player (2017-2022)
4.3 Global Next-Generation Biologics Average Price by Player (2017-2022)
4.4 Global Next-Generation Biologics Gross Margin by Player (2017-2022)
4.5 Next-Generation Biologics Market Competitive Situation and Trends
4.5.1 Next-Generation Biologics Market Concentration Rate
4.5.2 Next-Generation Biologics Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Next-Generation Biologics Sales, Revenue, Price Trend by Type
5.1 Global Next-Generation Biologics Sales and Market Share by Type (2017-2022)
5.2 Global Next-Generation Biologics Revenue and Market Share by Type (2017-2022)
5.3 Global Next-Generation Biologics Price by Type (2017-2022)
5.4 Global Next-Generation Biologics Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Next-Generation Biologics Sales, Revenue and Growth Rate of Antibodies (2017-2022)
5.4.2 Global Next-Generation Biologics Sales, Revenue and Growth Rate of Regenerative medicine (2017-2022)
5.4.3 Global Next-Generation Biologics Sales, Revenue and Growth Rate of Insulins (2017-2022)
5.4.4 Global Next-Generation Biologics Sales, Revenue and Growth Rate of Growth hormones (2017-2022)
5.4.5 Global Next-Generation Biologics Sales, Revenue and Growth Rate of Other (2017-2022)

6 Global Next-Generation Biologics Market Analysis by Application
6.1 Global Next-Generation Biologics Consumption and Market Share by Application (2017-2022)
6.2 Global Next-Generation Biologics Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Next-Generation Biologics Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Next-Generation Biologics Consumption and Growth Rate of Medical (2017-2022)
6.3.2 Global Next-Generation Biologics Consumption and Growth Rate of Scientific Research (2017-2022)
6.3.3 Global Next-Generation Biologics Consumption and Growth Rate of Other (2017-2022)

7 Global Next-Generation Biologics Sales and Revenue Region Wise (2017-2022)
7.1 Global Next-Generation Biologics Sales and Market Share, Region Wise (2017-2022)
7.2 Global Next-Generation Biologics Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Next-Generation Biologics Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Next-Generation Biologics Market Forecast (2022-2029)
8.1 Global Next-Generation Biologics Sales, Revenue Forecast (2022-2029)
8.1.1 Global Next-Generation Biologics Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Next-Generation Biologics Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Next-Generation Biologics Price and Trend Forecast (2022-2029)
8.2 Global Next-Generation Biologics Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.2.3 China Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.2.5 India Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Next-Generation Biologics Sales and Revenue Forecast (2022-2029)
8.3 Global Next-Generation Biologics Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Next-Generation Biologics Revenue and Growth Rate of Antibodies (2022-2029)
8.3.2 Global Next-Generation Biologics Revenue and Growth Rate of Regenerative medicine (2022-2029)
8.3.3 Global Next-Generation Biologics Revenue and Growth Rate of Insulins (2022-2029)
8.3.4 Global Next-Generation Biologics Revenue and Growth Rate of Growth hormones (2022-2029)
8.3.5 Global Next-Generation Biologics Revenue and Growth Rate of Other (2022-2029)
8.4 Global Next-Generation Biologics Consumption Forecast by Application (2022-2029)
8.4.1 Global Next-Generation Biologics Consumption Value and Growth Rate of Medical (2022-2029)
8.4.2 Global Next-Generation Biologics Consumption Value and Growth Rate of Scientific Research (2022-2029)
8.4.3 Global Next-Generation Biologics Consumption Value and Growth Rate of Other (2022-2029)
8.5 Next-Generation Biologics Market Forecast Under COVID-19

9 Industry Outlook
9.1 Next-Generation Biologics Market Drivers Analysis
9.2 Next-Generation Biologics Market Restraints and Challenges
9.3 Next-Generation Biologics Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Next-Generation Biologics Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Next-Generation Biologics Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Next-Generation Biologics Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......
  • Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......
  • Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154
    According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......
  • Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......
  • Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......
  • Next Generation Sequencing - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......
  • Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......
  • Global Genotyping Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128
    Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......
  • Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs